Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Hazard Mater ; 417: 126052, 2021 Sep 05.
Article in English | MEDLINE | ID: mdl-34000702

ABSTRACT

The development of synthetic methods to obtain high value-added mesoporous Al-MCM-41 from a low-cost silicon-aluminum source with low toxicity is an active research topic in solid waste resource utilization. In particular, the controlled synthesis of MCM-41 with a two-level pore distribution is a challenging task. In this work, the synthesis of unimodal and bimodal mesoporous Al-MCM-41s was achieved using acids with different degrees of ionization from coal gasification fine residue (CGFR) as bulk solid waste generated by the coal gasification process. We determined that the degree of acid ionization affected the self-assembly of inorganic/organic species as well as condensation processes, resulting in some changes of the hexagonal mesoscopic structure. The unimodal mesoporous Al-MCM-41 with acetic acid HAc and bimodal mesoporous Al-MCM-41s with an inorganic acid environment (HCl, HNO3 or H2SO4) could be effectively prepared in a controllable manner by the silicon and aluminum source obtained at alkali dissolution time 6 h and crystallization conditions at pH 10.5 and 383 K in 72 h. Moreover, the synthesis of Al-MCM-41-HAc with different SiO2/Al2O3 molar ratios (18-89) could also be realized by different alkali dissolution times. And alkali dissolution time (2-24 h) and the crystallization conditions (pH 4.5-11.5, temperatures 373-393 K, and time 48-96 h) also affected the formation of unimodal and bimodal mesoporous Al-MCM-41-HAc. In addition, the maximum adsorption amount onto bimodal mesoporous Al-MCM-41-H2SO4 (476.19 mg g-1 at 308 K) was larger than that onto unimodal mesoporous Al-MCM-41-HAc (243.90 mg g-1 at 303 K). The mesoporous Al-MCM-41s showed good stability.

2.
Sci Total Environ ; 648: 306-314, 2019 Jan 15.
Article in English | MEDLINE | ID: mdl-30121030

ABSTRACT

In the contaminated coastal sediments, variations of microbial community can reflect the impact of anthropogenic activities. The identification, evaluation and monitoring of the potential bio-indicator species and biomarker communities are vital for the ecological studies in sedimentary environments. Based on the high-throughput sequencing, the microbial communities were characterized in the sediments along the Yangtze Estuary and its coastal area. The results showed that the structure and composition of microbial communities varied greatly among different sampling sites at the phyla level, especially for Euryarchaeota. Metabolic pathway and quantitative PCR analyses suggested that the methane metabolism-related microbes were mainly included in the phylum of Euryarchaeota. Elevated abundances of methane metabolism-related microbes were found at Shidongkou (SDK) and Wusongkou (WSK), where microbes were seriously impacted by the wastewater treatment plant (WWTP) effluent and urban runoff. By comparing with the Euryarchaeota in WWTP sludge, the relatively high abundance of Euryarchaeota in sediment at SDK may be mainly related to the massive growth of indigenous species, promoted by anthropogenic nutrients. Moreover, redundancy discriminant analysis and correlation analysis revealed that methanogens and methanotrophs mainly respond to the nutrients and metals, such as total organic carbon, total phosphorus, total nitrogen, SO42-, NO2-, NH4+, Cr, and Zn, which were often related to human activities. Network analyses showed that the species related to the metabolism of methane may play a vital role in the interassociation among different microbial communities. Therefore, methanogens, methanotrophs and their community compositions could be considered as potential bio-indicator species and biomarker communities, indicating anthropogenic activities in the sediments along the Yangtze Estuary and its coastal area.


Subject(s)
Archaea/isolation & purification , Bacteria/isolation & purification , Estuaries , Geologic Sediments/microbiology , Microbiota , Biomarkers/analysis , China , Environment , RNA, Archaeal/analysis , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis
3.
Curr Microbiol ; 69(4): 429-35, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24838665

ABSTRACT

This study established a simple method of specifically detecting Salmonella species by amplifying fimW gene, which was involved in regulating Salmonella type I fimbriae expression. A pair of primers was designed to target and discriminate the 68 Salmonella strains of 23 Salmonella serovars available to us from 12 non-Salmonella strains of five different kinds of bacteria by polymerase chain reaction (PCR) amplification. Results showed that specific DNA fragment with an expected size of 477 bp was successfully amplified from all Salmonella serovars, while no target band was detected in non-Salmonella species. The sensitivity of this PCR-amplifying system reached to 1 pg DNA chromosome and 10(2) cfu of Salmonella enteritis strain CMCC(B) 50336. The above results demonstrated the method as a simple, sensitive, and specific way for Salmonella detection.


Subject(s)
Bacterial Proteins/genetics , Polymerase Chain Reaction/methods , Salmonella/genetics , DNA Primers/genetics , Gene Amplification , Salmonella/isolation & purification , Sensitivity and Specificity
4.
J Microbiol Immunol Infect ; 47(1): 57-62, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23352331

ABSTRACT

BACKGROUND: The fimbriae of Salmonella enterica serovar Enteritidis are used for colonization and invasion into host cells, and have drawn considerable interest because fimbriae can serve as potential immunogens against many pathogenic bacteria that colonize on epithelial surfaces. The purpose of the study is to use a molecular adjuvant, C3d, to enhance the immunogenicity of FimA proteins against Salmonella enterica serovar Enteritidis. METHODS: FimA of type I fimbriae from Salmonella enteritidis and FimA with one copy of mC3d, two copies of mC3d2 and three copies of mC3d3 were cloned into the expression vector pCold-TF. Soluble fusion proteins of FimA with different copy of mC3d were induced by IPTG and expressed into Escherichia coli BL21 (DE3). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) showed that the recombinant proteins from pCold-TF-fimA, TF-fimA-mC3d, TF-fimA-mC3d2, TF-fimA-mC3d3 were 70 kDa, 100 kDa, 130 kDa and 160 kDa, respectively. The fusion protein was recognized by rabbit anti-fimbriae polyclonal antibodies, and then visualized by goat anti-rabbit polyclonal antibodies with a chrome appearance by enzyme-subtract interaction. The recombinant proteins were purified by Ni-TED (tris-carboxymethyl ethylene diamine), immobilized metal ion affinity chromatography (IMAC). Balb/c mice were subcutaneously immunized with the purified proteins and the immune response was monitored by an enzyme-linked immunosorbent assay (ELISA) for FimA-specific antibody. The immunized mice were challenged with a 10-fold LD50 dose (i.e., 100 CFU) of Salmonella enterica serovar Enteritidis standard strain (SD-2) 1 week after the second immunization. RESULTS: The immunized mice with the fusion proteins FimA-mC3d2 and FimA-mC3d3 had increased levels of ELISA titer of antibody that were 2 and 4 logs, respectively, more immunogenic than the TF-FimA protein alone. The challenge results showed that immune protection rate in the mice immunized with 10 µg of FimA, FimA-mC3d2, and FimA-mC3d3 were 50%, 75% and 100%, respectively. CONCLUSION: We conclude that mC3d can be expressed in a prokaryotic vector and enhance the immune response of the recombinant protein. FimA-mC3d3 is potentially a subunit vaccine against S. enterica serovar Enteritidis infection.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Antigens, Bacterial/immunology , Complement C3d/administration & dosage , Fimbriae Proteins/immunology , Salmonella Infections, Animal/prevention & control , Salmonella Vaccines/immunology , Salmonella enteritidis/immunology , Vaccination/methods , Adjuvants, Immunologic/genetics , Animals , Antibodies, Bacterial/blood , Antigens, Bacterial/genetics , Complement C3d/genetics , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Fimbriae Proteins/genetics , Injections, Subcutaneous , Mice , Mice, Inbred BALB C , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Salmonella Infections, Animal/immunology , Salmonella Vaccines/administration & dosage , Salmonella Vaccines/genetics , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology
5.
PLoS One ; 3(11): e3716, 2008.
Article in English | MEDLINE | ID: mdl-19005571

ABSTRACT

BACKGROUND: Stress Granules (SG) are sites of accumulation of stalled initiation complexes that are induced following a variety of cellular insults. In a genetic screen for factors involved in protecting human myoblasts from acute oxidative stress, we identified a gene encoding a protein we designate SGNP (Stress Granule and Nucleolar Protein). METHODOLOGY/PRINCIPAL FINDINGS: A gene-trap insertional mutagenesis screen produced one insertion that conferred resistance to sodium arsenite. RT-PCR/3' RACE was used to identify the endogenous gene expressed as a GFP-fusion transcript. SGNP is localized in both the cytoplasm and nucleolus and defines a non-nucleolar compartment containing 5.8S rRNA, a component of the 60S ribosomal subunit. Under oxidative stress, SGNP nucleolar localization decreases and it rapidly co-localizes with stress granules. The decrease in nucleolar SGNP following oxidative stress was accompanied by a large increase in nucleolar 5.8S rRNA. Knockdown of SGNP with shRNA increased global mRNA translation but induced growth arrest and cell death. CONCLUSIONS: These results suggest that SGNP is an essential gene that may be involved in ribosomal biogenesis and translational control in response to oxidative stress.


Subject(s)
Active Transport, Cell Nucleus/genetics , Cell Nucleolus , Heat-Shock Proteins/genetics , Nuclear Proteins/genetics , Oxidative Stress/genetics , RNA, Ribosomal/metabolism , Animals , Antibodies, Monoclonal , Apoptosis , Arsenites/pharmacology , Biological Transport , Gene Expression Regulation , Humans , Mutagenesis, Insertional , Mutation , Myoblasts, Skeletal , Oxidants/pharmacology , Protein Structure, Tertiary , Rabbits , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis , Sodium Compounds/pharmacology
6.
Aging Cell ; 6(4): 515-23, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17559502

ABSTRACT

Cultured human myoblasts fail to immortalize following the introduction of telomerase. The availability of an immortalization protocol for normal human myoblasts would allow one to isolate cellular models from various neuromuscular diseases, thus opening the possibility to develop and test novel therapeutic strategies. The parameters limiting the efficacy of myoblast transfer therapy (MTT) could be assessed in such models. Finally, the presence of an unlimited number of cell divisions, and thus the ability to clone cells after experimental manipulations, reduces the risks of insertional mutagenesis by many orders of magnitude. This opportunity for genetic modification provides an approach for creating a universal donor that has been altered to be more therapeutically useful than its normal counterpart. It can be engineered to function under conditions of chronic damage (which are very different than the massive regeneration conditions that recapitulate normal development), and to overcome the biological problems such as cell death and failure to proliferate and migrate that limit current MTT strategies. We describe here the production and characterization of a human myogenic cell line, LHCN-M2, that has overcome replicative aging due to the expression of telomerase and cyclin-dependent kinase 4. We demonstrate that it functions as well as young myoblasts in xenotransplant experiments in immunocompromized mice under conditions of regeneration following muscle damage.


Subject(s)
Aging/physiology , Cellular Senescence/physiology , Cyclin-Dependent Kinase 4/metabolism , Muscle Development , Muscles/physiology , Myoblasts/physiology , Telomerase/metabolism , Animals , Cell Division , Cell Line , Genes, cdc , Humans , Mice , Muscular Dystrophies/therapy , Myoblasts/cytology , Myoblasts/enzymology , Myoblasts/transplantation , Regeneration , Satellite Cells, Skeletal Muscle/physiology , Telomere , Transplantation, Heterologous
7.
Cancer Res ; 67(3): 1121-9, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17283146

ABSTRACT

We determined previously that a novel human telomerase RNA (hTR) antagonist, GRN163L, inhibited the tumorigenic potential of A549-luciferase (A549-luc) lung cancer cells in vitro and in vivo. Further studies revealed that A549-luc cells were also morphologically altered by GRN163L. A549-luc cells treated before cell attachment with a single dose of GRN163L only weakly attached to the substrate and remained rounded, whereas control mismatch-treated cells exhibited typical epitheloid appearance and adhesion properties. These morphologic changes were independent of hTR expression and telomerase inhibition and were unrelated to telomere length. This effect is dependent on the molecular properties of the lipid moiety, the phosphorothioate backbone, and the presence of triplet-G sequences within the GRN163L structure. Altered adhesion was manifested by a 50% reduction in rapid cellular attachment and a 3-fold decrease in total cell spreading surface area. Administration of a single dose of GRN163L (15 mg/kg) at the time of cell inoculation, using an in vivo model of lung cancer metastasis, resulted in significant reductions in tumor burden at days 13, 20, and 27 of tumor progression. Thus, the potent antimetastatic effects of GRN163L may be related, in part, to the antiadhesive effects of this novel cancer therapeutic conferred via specific structural determinants and that these effects are independent of telomerase inhibition or telomere shortening.


Subject(s)
Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/pathology , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Oligonucleotides/pharmacology , Oligopeptides/genetics , RNA/antagonists & inhibitors , Telomerase/antagonists & inhibitors , Amides/pharmacology , Animals , Carcinoma, Non-Small-Cell Lung/genetics , Cell Adhesion/drug effects , Cell Adhesion/genetics , Cell Line, Tumor , Humans , Lung Neoplasms/genetics , Mice , Mice, Nude , Oligonucleotides/genetics , Phosphoric Acids/pharmacology , RNA/genetics , Telomerase/genetics , Telomere/drug effects , Telomere/genetics , Xenograft Model Antitumor Assays
8.
Dev Biol ; 288(2): 502-13, 2005 Dec 15.
Article in English | MEDLINE | ID: mdl-16310178

ABSTRACT

The Serum Response Factor (SRF) coactivator myocardin stimulates the transcription of multiple muscle genes during cardiac and smooth muscle development. Mouse embryos lacking myocardin die during the earliest stages of smooth muscle development and fail to express multiple smooth muscle marker genes in the embryonic dorsal aorta and other vascular structures. In this study, we used mutant embryonic stem cell lines to further define the role of myocardin in smooth muscle differentiation and vascular development. Misexpression of myocardin in undifferentiated muscle stem cells resulted in efficient activation of smooth muscle genes, and weaker activation of genes involved in cardiac and skeletal muscle differentiation. Remarkably, myocardin(-/-) embryonic stem cell lines differentiated into smooth muscle cells in vitro, although these cells expressed significantly decreased levels of smooth muscle contractile genes. Moreover, genetically labeled myocardin(-/-) ES cells were able to contribute to smooth muscle lineages in vivo. These results indicate that while myocardin function is sufficient for activation of SRF-dependent muscle gene expression in multiple cell types, myocardin-independent mechanism(s) can suffice for expression in some smooth muscle lineages.


Subject(s)
Cell Differentiation/physiology , Gene Expression Profiling , Muscle, Smooth/cytology , Muscle, Smooth/metabolism , Nuclear Proteins/metabolism , Stem Cells/cytology , Trans-Activators/metabolism , Animals , Cell Line , Cell Lineage/physiology , Embryo, Mammalian/cytology , Gene Expression Regulation, Developmental , Humans , Mice , Mice, Mutant Strains , Muscle, Skeletal/cytology , Muscle, Skeletal/embryology , Muscle, Skeletal/metabolism , Muscle, Smooth/embryology , Mutation , Myocardium/cytology , Myocardium/metabolism , Nuclear Proteins/genetics , Oligonucleotide Array Sequence Analysis , Trans-Activators/genetics
9.
Development ; 130(12): 2579-88, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12736203

ABSTRACT

Stem cell niches are specific regulatory microenvironments formed by neighboring stromal cells. Owing to difficulties in identifying stem cells and their niches in many systems, mechanisms that control niche formation and stem cell recruitment remain elusive. In the Drosophila ovary, two or three germline stem cells (GSCs) have recently been shown to reside in a niche, in which terminal filaments (TFs) and cap cells are two major components. We report that signals from newly formed niches promote clonal expansion of GSCs during niche formation in the Drosophila ovary. After the formation of TFs and cap cells, anterior primordial germ cells (PGCs) adjacent to TFs/cap cells can develop into GSCs at the early pupal stage while the rest directly differentiate. The anterior PGCs are very mitotically active and exhibit two division patterns with respect to cap cells. One of these patterns generates two daughters that both contact cap cells and potentially become GSCs. Our lineage tracing study confirms that one PGC can generate two or three GSCs to occupy a whole niche ('clonal expansion'). decapentaplegic (dpp), the Drosophila homolog of human bone morphogenetic protein 2/4, is expressed in anterior somatic cells of the gonad, including TFs/cap cells. dpp overexpression promotes PGC proliferation and causes the accumulation of more PGCs in the gonad. A single PGC mutant for thick veins, encoding an essential dpp receptor, loses the ability to clonally populate a niche. Therefore, dpp is probably one of the mitotic signals that promote the clonal expansion of GSCs in a niche. This study also suggests that signals from newly formed niche cells are important for expanding stem cells and populating niches.


Subject(s)
Cell Division/physiology , Drosophila/embryology , Ovary/embryology , Ovum/growth & development , Animals , Drosophila Proteins/metabolism , Female , Signal Transduction/physiology
10.
Science ; 296(5574): 1855-7, 2002 Jun 07.
Article in English | MEDLINE | ID: mdl-12052957

ABSTRACT

How stem cells are recruited to and maintained in their niches is crucial to understanding their regulation and use in regenerative medicine. Here, we demonstrate that DE-cadherin-mediated cell adhesion is required for anchoring germline stem cells (GSCs) in their niches in the Drosophila ovary. Two major components of this adhesion process, DE-cadherin and Armadillo/beta-catenin, accumulate at high levels in the junctions between GSCs and cap cells, one of the niche components. Removal of these proteins from GSCs results in stem cell loss. Furthermore, DE-cadherin is required for recruiting GSCs to their niche. Our study demonstrates that anchorage of GSCs in their niche by DE-cadherin-mediated adhesion is important for stem cell maintenance and function.


Subject(s)
Adherens Junctions/physiology , Cadherins/physiology , Drosophila Proteins , Drosophila/physiology , Oocytes/cytology , Stem Cells/physiology , Trans-Activators , Alleles , Animals , Armadillo Domain Proteins , Cadherins/genetics , Cell Adhesion , Cell Differentiation , Drosophila/cytology , Drosophila/genetics , Drosophila/growth & development , Female , Insect Proteins/genetics , Insect Proteins/physiology , Larva/physiology , Mutation , Oocytes/physiology , Oocytes/ultrastructure , Ovary/cytology , Ovary/growth & development , Ovary/physiology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/physiology , Signal Transduction , Stem Cells/cytology , Stem Cells/ultrastructure , Transcription Factors , Wnt1 Protein
11.
Breast Cancer Res Treat ; 71(1): 47-57, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11859873

ABSTRACT

ErbB-3 (HER3) is a member of the epidermal growth factor receptor family. Increasing evidence suggests that elevated expression of ErbB-3 is important for malignancy. In this study, we found that elevated levels of ErbB-3 expression did not occur in the absence of AP-2gamma in a panel of human mammary epithelial and fibroblasts cell lines. In contrast, there was no association between the expression of AP-2alpha or AP-2beta and the level of ErbB-3, or between AP-2alpha and AP-2gamma double positivity and ErbB-3 expression. In co-transfection experiments, exogenous expression of AP-2gamma robustly activated ErbB-3 promoter activity. Moreover, expression of a dominant negative AP-2 protein, AP-2delta (deleted residues 31-117), not only repressed the ErbB-3 promoter activity but also suppressed endogenous ErbB-3 transcription in the ErbB-3 overexpressing cell line MRC-5VA. Overexpression of AP-2A resulted in a decreased proliferation rate and inhibitin of colony formation. Taken together, these data strongly support a role for the AP-2 gene family, in particular, AP-2gamma, in the control of ErbB-3 expression. Interference with the function of transcription factor AP-2 might provide a potential strategy for modulation of the malignant phenotype.


Subject(s)
Breast Neoplasms/genetics , Breast/pathology , Cell Transformation, Neoplastic , DNA-Binding Proteins/pharmacology , Gene Expression Regulation, Neoplastic , Genes, erbB , Receptor, ErbB-3/biosynthesis , Transcription Factors/pharmacology , Breast/cytology , Breast Neoplasms/physiopathology , Cell Division , Female , Fibroblasts/physiology , Humans , Lung/cytology , Phenotype , Transcription Factor AP-2
SELECTION OF CITATIONS
SEARCH DETAIL
...